Fintel reports that on November 13, 2025, D. Boral Capital maintained coverage of Medicus Pharma (NasdaqCM:MDCX) with a Buy recommendation. Analyst Price Forecast Suggests 916.96% Upside As of ...

The pharmaceutical industry has immense pressure to deliver advanced and novel therapies to patients worldwide but faces monumental challenges in drug development. On average, the journey from ...

Steven Paul’s “How to improve R&D productivity: the pharmaceutical industry's grand challenge” published in Nature Reviews Drug Discovery in 2010 is one of the highest cited and most frequently quoted ...

Gland Pharma Ltd (NSE:GLAND) reports a 6% revenue increase, driven by US market performance and strategic product launches.